Bicocca Open Archive

BOA (Bicocca Open Archive) è l’archivio istituzionale che raccoglie, conserva e dissemina la produzione scientifica dell’Università degli Studi di Milano - Bicocca. BOA è un modulo integrato nella piattaforma di gestione IRIS.

Qualità e ricerca: è riconfermata la certificazione ISO 9001 per il processo di validazione delle pubblicazioni in IRIS-BOA

La norma ISO 9001 definisce i requisiti che il Sistema di Gestione per la Qualità di un'organizzazione deve dimostrare di soddisfare per garantire un livello adeguato di qualità del proprio prodotto/servizio: il 27 novembre 2024, dopo un costante lavoro di monitoraggio sul processo, SIR ha conseguito un rinnovo della certificazione di qualità.
Il certificato ufficiale ISO è disponibile a questo link.

Prodotti recenti

Policies, Practices, and Imaginaries: Urban Regeneration in China - Chengdu as a Case

Against the backdrop of China’s very recent urbanisation boom - urbanisation rate has tripled during the last thirty years - as well as the roaring real estate market mirroring its market-oriented reform, Chinese cities have been undergoing rapid and extensive regeneration at the same time. Such ever-growing rebuilding processes are taking place regularly in almost every city, not only large metropolises; in a way, urban regeneration has become a hegemonic project at all levels of public admi...

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

Background: Although SARS-CoV-2 vaccines immunogenicity in patients with cancer has been investigated, whether they can significantly improve the severity of COVID-19 in this specific population is undefined. Methods: Capitalizing on OnCovid (NCT04393974) registry data we reported COVID-19 mortality and proxies of COVID-19 morbidity, including post-COVID-19 outcomes, according to the vaccination status of the included patients. Results: 2090 eligible patients diagnosed with COVID-19 between 0...

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Background: COVID-19 sequelae can affect about 15% of patients with cancer who survive the acute phase of SARS-CoV-2 infection and can substantially impair their survival and continuity of oncological care. We aimed to investigate whether previous immunisation affects long-term sequelae in the context of evolving variants of concern of SARS-CoV-2. Methods: OnCovid is an active registry that includes patients aged 18 years or older from 37 institutions across Belgium, France, Germany, Italy, S...

Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper

Breast cancer represents the most commonly diagnosed neoplasm worldwide and the HER2-positive subtype accounts for nearly 1 in 5 breast cancers. The majority of patients with breast cancer present with an early-stage disease upon diagnosis, which is thus susceptible to virtually curative treatment strategies. For a stage, I T1a/b N0 HER2-positive disease, upfront surgery followed by adjuvant therapy is the preferred approach. However, there is some uncertainty regarding the appropriate manage...

Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer - Immun-HER trial (GOIRC-01-2016)

Background It is possible to induce immunomodulation in HER2-positive breast cancer (BC) by modifying the route of administration of trastuzumab. Methods In this multicenter randomized phase II trial, all enrolled patients (pts) with T2-T4d HER2-positive BC received 3 cycles of neoadjuvant treatment (NAT) with fluorouracil, epirubicin and cyclophosphamide every 3 weeks (q21), followed by docetaxel/pertuzumab plus intravenous trastuzumab (arm A) or, docetaxel/pertuzumab plus subcutaneous (SC) ...

Scopri
Dipartimento
  • DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE5557
  • DIPARTIMENTO DI ECONOMIA, METODI QUANTITATIVI E STRATEGIE DI IMPRESA5064
  • DIPARTIMENTO DI FISICA "GIUSEPPE OCCHIALINI"11231
  • DIPARTIMENTO DI GIURISPRUDENZA (SCHOOL OF LAW)9901
  • DIPARTIMENTO DI INFORMATICA, SISTEMISTICA E COMUNICAZIONE5853
  • DIPARTIMENTO DI MATEMATICA E APPLICAZIONI3405
  • DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)30210
  • DIPARTIMENTO DI PSICOLOGIA10676
  • DIPARTIMENTO DI SCIENZA DEI MATERIALI7160
  • DIPARTIMENTO DI SCIENZE DELL'AMBIENTE E DELLA TERRA (DEPARTMENT OF EARTH AND ENVIRONMENTAL SCIENCES - DISAT)9905
  • DIPARTIMENTO DI SCIENZE ECONOMICO-AZIENDALI E DIRITTO PER L'ECONOMIA5374
  • DIPARTIMENTO DI SCIENZE UMANE PER LA FORMAZIONE "RICCARDO MASSA"12903
  • DIPARTIMENTO DI SOCIOLOGIA E RICERCA SOCIALE8029
  • DIPARTIMENTO DI STATISTICA E METODI QUANTITATIVI3967
Tipologia
  • 01 - Articolo su rivista77513
  • 02 - Intervento a convegno20888
  • 03 - Contributo in libro18222
  • 04 - Monografia2822
  • 07 - Tesi di dottorato Bicocca post 20092674
  • 99 - Altro2553
  • 05 - Curatele1882
  • 06 - Brevetti290
  • 04c - Traduzione di libro151
  • 03b - Traduzione in libro143
  • 09 - Tesi di dottorato141
  • 01b - Traduzione su rivista78
  • 04b - Edizione critica - fonti inedite - commento scientifico52
  • 08 - Tesi di specializzazione16
Data di pubblicazione
  • In corso di stampa93
  • 2020 - 202533108
  • 2010 - 201960163
  • 2000 - 200925365
  • 1990 - 19996307
  • 1980 - 19891993
  • 1970 - 1979386
  • 1966 - 19699

127.424

pubblicazioni

23.352

open access

7.483.178

download

41.503

full text

9.528

autori